Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Insider Tips From a Capital Markets Guru on Trends

When it comes to capital markets, there are few more experienced to teach the do’s and don’ts of trading than Howard Katz – Managing Director of Mackie Research. In this insightful, intriguing and entertaining interview with Dave Jackson of...

PROFIT! A NEW Stockhouse Vodcast Series. Eps. 1

Get to know capital market moguls, mavens and management teams in a more relaxed setting. Episodes open with fun, rapid-fire questions, setting the tone for a more informal one-on-one session. You won’t want to miss our weekly releases featuring thought ...

Breaking Down the Multibillion-Dollar Biologicals Market

(Click to play video) Investors aware of the biologicals market know that it has been quietly building up over the last few years. From mergers and acquisition deals north of a billion dollars to a steady presence in industry and mainstream news, the sector is o...

PROFIT! A NEW Stockhouse Vodcast Series

Welcome to our exciting, new “vodcast“ (def: video podcast) series – PROFIT! Get to know capital market moguls, mavens and management teams in a more relaxed setting. Episodes open with fun, rapid-fire questions, setting the tone for a more informal one-on-one. A...

In Conversation with Willow Biosciences – Perspectives from an Analyst & CEO

Valuation, investor perception and Willow’s ( TSX: WLLW ) market opportunity as it closes in on the production of commercial quantities of pharma grade CBD and rare cannabinoids were amongst a variety of topics covered in a recent conversation between Gr...

Novamind Selected by Merck to Advance Research for Treatment-Resistant Depression

Novamind’s subsidiary, Cedar Clinical Research, to serve as a key clinical research site Independent validation of the expertise and capabilities of Novamind in managing clinical trials Adds to established track record conducting research a...

Gold, Silver and the Experts That Know Metals, Mining & Markets

From March 1 - 4, 2020, Stockhouse Media reported LIVE from the Prospectors & Developers Association of Canada (PDAC) convention floor with interviews, live reports, and news updates from many of the mining industry’s major movers and shakers. Thousand...

Tocvan: Drill, Brodie, Drill

When management changes at a junior resource company it often worries shareholders. Is there a “problem”? Mark Smethurst has stepped down as the COO of Tocvan Ventures ( CSE: TOC ) but remains a director of the company. Brodie Sutherland has ...

A bright exploration project adjacent to the Historic Obuasi Mine

Ghana is one of the most prolific gold mining jurisdictions in the world, top in African production and sixth globally behind the United States. Pelangio Exploration (TSXV:PX , OTC:PGXPF , Forum ), a Canadian company with projects in Ghana and Canada, had been relativ...

'Data Readouts Approaching in Two Pivotal Trials' for Biopharma Targeting Unmet Needs

The next steps for each of the programs are outlined in a Dawson James Securities report. In an Aug. 14 research note, Dawson James Securities analyst Jason Kolbert reported that Soligenix Inc. (SNGX:NASDAQ) "is now focused on the two pivotal programs, i...
1 2 3 4 5 6 7 8 9 10 ...